ETL4 anticorps (C-Term)
Aperçu rapide pour ETL4 anticorps (C-Term) (ABIN7467839)
Antigène
Voir toutes ETL4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the C-terminus region of human SKT. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- ICC/IF: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.89 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- ETL4 (Enhancer Trap Locus 4 (ETL4))
-
Autre désignation
- KIAA1217
-
Sujet
- KIAA1217 , ETL4 , SKT,Required for normal development of intervertebral disks.
-
Poids moléculaire
- 97 kDa
-
ID gène
- 56243
-
UniProt
- Q5T5P2
Antigène
-